4 August 2026 · Digital endpoints

How do continuous sensor data become trustworthy trial endpoints?

A 30-minute pack about wearables, high-frequency data, missingness, endpoint derivation and regulatory-grade traceability.

DifficultyC1
Time30 minutes
Main sourcenpj Digital Medicine
OutputEndpoint pipeline

Why this reading

More observations create more derivation decisions.

FDA will hold a workshop on 27 August 2026 about statistical considerations for digitally-derived endpoints. This review shows current use patterns and practical barriers.

For SP teams, continuous data require explicit quality flags, valid-wear rules, aggregation windows, software versions and traceability from raw signal to analysis value.

Reading order

Your 30-minute plan.

0-3 minPreview

Predict why continuous data do not automatically produce better endpoints.

3-15 minMain article

Read the Abstract, Introduction, Results and Discussion.

15-20 minFDA workshop

Identify statistical and data-standard questions.

20-25 minRegulatory guide

Review fit-for-purpose implementation steps.

25-30 minOutput

Design one sensor-endpoint derivation and QC pipeline.

Open-access sources

Current evidence and regulatory direction.

Brief background

From a sensor stream to one analysis value.

The review identified 48 studies across 36 countries. Thirty-eight studies used physiological sensor data, and 36 of these used continuous glucose monitoring.

Twelve studies reported sensor-based clinical outcomes such as physical activity, movement or sleep. Most devices were wrist-worn, and half combined sensor measures with other clinical assessments.

Continuous data may better reflect daily life, but device variation, software updates, insufficient training, non-wear and data-quality problems complicate analysis.

A programmer must convert raw timestamps into analysis-ready values using pre-specified quality checks, valid-day thresholds, aggregation windows, baseline rules and missing-data methods.

Key vocabulary

Fifteen terms worth retrieving.

Term中文Meaning / use
digital health technology数字健康技术A sensor, software or connected system used to collect health data.
digitally-derived endpoint数字化衍生终点A trial endpoint calculated from data captured by a digital technology.
continuous glucose monitoring连续血糖监测Frequent measurement of interstitial glucose over time.
sensor-based functional outcome传感器功能性结局A passive measure of functioning, such as activity or sleep.
performance outcome表现性结局A measure produced while a participant performs a standardized task.
high-frequency data高频数据Measurements collected many times within a short period.
data aggregation window数据聚合窗口The time interval used to summarize raw observations.
wear-time compliance佩戴依从性How consistently participants use a device as required.
missingness mechanism缺失机制The process explaining why observations are absent.
fit-for-purpose适合预定用途Suitable and sufficiently validated for a defined context of use.
technical validation技术验证Evidence that a device measures its intended signal accurately.
analytical validation分析验证Evidence that algorithms correctly transform raw signals into measures.
clinical validation临床验证Evidence that a measure reflects a meaningful health concept.
software update软件更新A device or algorithm change that may alter generated data.
estimand alignment估计目标一致性Consistency between the endpoint, intercurrent events and treatment effect of interest.

Useful phrases

Language for a digital-endpoint discussion.

  1. derive a clinically meaningful endpoint from continuous data - The team must derive a clinically meaningful endpoint from continuous data.
  2. pre-specify the aggregation algorithm - The analysis plan should pre-specify the aggregation algorithm.
  3. distinguish device non-wear from clinical inactivity - Programmers must distinguish device non-wear from clinical inactivity.
  4. define a minimum valid wear-time threshold - The protocol should define a minimum valid wear-time threshold.
  5. assess sensitivity to missing-data assumptions - The analysis should assess sensitivity to missing-data assumptions.
  6. maintain traceability from raw signal to endpoint - The pipeline must maintain traceability from raw signal to endpoint.
  7. lock the device and software version - The study should lock the device and software version where possible.
  8. combine sensor measures with complementary assessments - Sensor measures may be combined with complementary assessments.
  9. evaluate whether the measure is fit for purpose - The sponsor must evaluate whether the measure is fit for purpose.
  10. document every transformation step - The specification should document every transformation step.

Comprehension

Five questions.

  1. What types of sensor-derived data were most common?
  2. Why is CGM more mature than activity or sleep endpoints?
  3. What problems can software changes create?
  4. Why distinguish non-wear from true inactivity?
  5. Which derivation decisions should be pre-specified?

Retelling

Say it three times.

  • 30 seconds · Review sample -> common technology -> main barrier.
  • 45 seconds · Raw signal -> QC -> wear time -> aggregation -> endpoint.
  • 60 seconds · Explain the impact on ADaM and TFL programming.

5-minute output task

Design a sensor-derived endpoint pipeline.

  1. Minute 1: Choose one endpoint.
  2. Minutes 2-3: Define raw input, quality flags, valid days, aggregation and baseline.
  3. Minute 4: Add version, timezone, missing-data, QC and traceability controls.
  4. Minute 5: State when the endpoint is analysis-ready.

One sentence to keep

Continuous data create richer evidence only when the endpoint algorithm, missing-data rules and software lineage are explicit, validated and reproducible.